Your session is about to expire
← Back to Search
4PCP Training for Chronic Pain (4PCP Trial)
4PCP Trial Summary
This trial seeks to improve chronic pain treatment & outcomes for all, potentially at a lower cost. A startup will provide the program & results will show if it works.
4PCP Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria below4PCP Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.4PCP Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not speak English.Doctors who work in general medicine (such as for adults or families) or in women's health.I am unable to complete questionnaires or participate in study training and evaluations.I have visited this medical practice at least twice before.I have had chronic pain for over 3 months, with no surgery planned.I am between 14 and 80 years old and speak English.I am unable to complete questionnaires due to a condition like stroke or dementia.I have sickle cell disease.You are not a doctor who focuses on general healthcare for patients.You are being treated for pain by a specialist, not your regular doctor.
- Group 1: 4PCP Course (for practitioners only)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any existing opportunities to join this clinical trial?
"According to clinicaltrials.gov, this medical trial is actively recruiting patients. The study was first publicized on November 9th 2022 and the most recent update came a week later on November 16th 2022."
Who is eligible to join this medical research project?
"This trial is accepting 1188 individuals aged between 14 and 80 who suffer from persistent pain. Prospective participants must be physicians in primary care, have a minimum of one year's experience with the practice, understand English both orally and written, possess an identifiable patient base afflicted by chronic non-malignant pain for over three months at a rate of intensity greater than 3/10 more than half the time without any impending or scheduled surgical procedures. Furthermore, they should also demonstrate capability to answer surveys and partake in research training sessions as well as assessments."
Does the protocol of this clinical investigation encompass individuals aged eighty and above?
"Consistent with the prerequisites for study participation, patients aged 14 to 80 are eligible."
What aims is this trial endeavoring to accomplish?
"This trial will focus on the Participant Pain, Enjoyment of Life and General Activity (PEG-3) metric over a period spanning 6 months before to 3 years after training. Secondary objectives include changes in Practitioner Chronic pain Attitudes and Beliefs Questionnaire (PABS-PT), Participant Pain Interference (PI), and Participant Generalized Anxiety Disorder (GAD-7)."
What is the cumulative tally of participants enrolled in this experiment?
"Affirmative. Clinicaltrials.gov data displays that this trial is actively enrolling patients, since November 9th 2022. A total of 1188 individuals are to be recruited across 5 clinical centers and the study was most recently updated on 16th November 2022."
How many locations have been approved to execute this trial?
"Presently, 5 different sites are recruiting patients for this trial. These locations include Milwaukee, Madison and Cleveland with two additional centres available. If you decide to join the study, it is important to choose a clinic close by in order to minimize commuting needs."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger